8‐Oxoguanine Modified CircMTUS1 Drives PABPC1 Phase Separation to Promote Gastric Cancer Progression and Cisplatin Resistance via Autophagy
Advanced Science · 2026
DOI: 10.1002/advs.76466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Lei Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Autophagy, Stomach Neoplasms, Cisplatin, Guanine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, General Program of China Postdoctoral Science Foundation, General Program of Nanjing Postdoctoral Science Foundation.
Abstract (Originalsprache)
Gastric cancer (GC) is a major global health concern, as its prevention and treatment remain significant challenges. The 8‐oxoguanine (o8G) modification of circRNAs, alongside their capacity to orchestrate liquid‐liquid phase separation (LLPS) and autophagy, plays a pivotal role in driving tumor progression and determining therapeutic outcomes. Here, we identified the downregulation of circMTUS1 in GC and elucidated the upstream and downstream mechanisms governing its role in tumor progression and chemoresistance. We demonstrated that YBX1 induces o8G modification, which reduces circMTUS1 stability. Notably, circMTUS1 restoration markedly inhibits tumor growth both in vitro and in vivo. Mechanistically, circMTUS1 targeted PABPC1 through the LLPS to regulate stress granules (SG) formation and autophagy to inhibit GC progression and to affect the sensitivity to chemotherapy. Furthermore, the small‐molecule SG inhibitor ISRIB acts synergistically with circMTUS1 to significantly sensitize GC cells to cisplatin. Collectively, our data demonstrate that circMTUS1 suppresses GC progression through a pathway involving YBX1‐dependent o8G modification and PABPC1‐mediated regulation of SG and autophagy. Consequently, targeting circMTUS1 or its downstream SG may offer an effective strategy to enhance the chemosensitivity of gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Endocrinology, Children's Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Yini Dang
Förderung
- National Natural Science Foundation of China
- General Program of China Postdoctoral Science Foundation
- General Program of Nanjing Postdoctoral Science Foundation
- Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University
Zitieren
APA
Peng, L., Li, L., Zhu, Z., Li, C., Sang, H., Zhang, G., Li, X., Dang, Y., & Li, Y. (2026). 8‐Oxoguanine Modified CircMTUS1 Drives PABPC1 Phase Separation to Promote Gastric Cancer Progression and Cisplatin Resistance via Autophagy. Advanced Science. https://doi.org/10.1002/advs.76466
Vancouver
Peng L, Li L, Zhu Z, Li C, Sang H, Zhang G, et al. 8‐Oxoguanine Modified CircMTUS1 Drives PABPC1 Phase Separation to Promote Gastric Cancer Progression and Cisplatin Resistance via Autophagy. Advanced Science. 2026. doi:10.1002/advs.76466
BibTeX
@article{Peng2026,
author = {Peng, Lei and Li, Lurong and Zhu, Zhenghui and Li, Chenyang and Sang, Huaiming and Zhang, Guoxin and Li, Xuan and Dang, Yini and Li, Yuanyuan},
title = {8‐Oxoguanine Modified CircMTUS1 Drives PABPC1 Phase Separation to Promote Gastric Cancer Progression and Cisplatin Resistance via Autophagy},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76466}
}
EUVIMED